ANG Lifesciences India Limited IPO

Apply 0
Avoid 0

ANG Lifesciences India Limited is a pharmaceutical company whose engaged in the business of manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India.
Company’s products include sterile dry powder vials for anti-biotics, anti-ulcerant, glucocorticoid and anti-inflammatory, anti-malarial, and anaesthetic. It manufactures products in compliance with GMP requirements.
However, Company that currently operates at an average capacity utilization of 70% for last two fiscals hopes to achieve 90% plus in coming years. ANGL is likely to consider acquisition options as well to enhance its manufacturing capacities. Its customer list includes Wockhardt, DHS Maharashtra, Global Hospitals, Elder, Emcure, BPPI, Govt. of Haryana, Hetero Healthcare etc.

ANG Lifesciences India Limited IPO Stock Quote & Charts



  • Open: 43.10
  • High - Low: 43.10 - 43.10
  • Previous Close: 42.00
  • Total Traded Volume: 1600
  • Updated On: 27-Jan-2020

Objects of the ANG Lifesciences India Limited IPO:

1. To meet the working capital requirement 2. To meet the expenses of the Issue

ANG Lifesciences India Limited IPO Details:

Open Date: Aug 29 2017
Close Date: Aug 31 2017
Total Shares: 1,500,800
Face Value: ₹ 10 Per Equity Share
Issue Type: Fixed Price Issue IPO
Issue Size: 12.01 Cr.
Lot Size: 1600 Shares
Issue Price: ₹ 80 Per Equity Share
Listing At: BSE SME
Listing Date: Sep 08 2017

Promoters And Management:

1. Rajesh Gupta 2. Saruchi Gupta

Lead Manager of ANG Lifesciences India Limited IPO:

  1. Guiness Corporate Advisors Private Limited

Registrar of ANG Lifesciences India Limited IPO:

  1. Bigshare Services Private Limited

Company Address:

ANG Lifesciences India Ltd Darbara Complex SCO 113 I Flr, Dist. Shopping Centre B Block, Amritsar - 143001 Phone: +91 0183 5070118 Email: Website:

Discussion on ANG Lifesciences India Limited IPO:

Leave a Reply